Clinical Trial Update: Evaluation of Viatar™ Oncopheresis System in Removing CTC From Whole Blood [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on Viatar's Oncopheresis System for removing circulating tumor cells from whole blood in metastatic cancer, spanning Phase 1 and Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Viatar Oncopheresis System

Snippet

Sponsor: Viatar LLC | Conditions: Metastatic Cancer | Phase 1, Phase 2 | Status: UNKNOWN